RAINES MERILEE 4

What Happened

• Merilee Raines, a director of TransMedics Group, Inc. (TMDX), was granted 2,922 restricted stock units (RSUs) on 2026-05-20. The award is reported as an "A" (award/grant) transaction and shows $0 cash paid at grant (typical for RSU awards).

Key Details

• Transaction date: 2026-05-20; Form 4 filed: 2026-05-22 (timely within the 2-business-day reporting window).
• Transaction type/code: Award/Grant (A).
• Shares/units granted: 2,922 RSUs; reported acquisition price: $0.00 (no cash paid at grant).
• Shares owned after transaction: Not specified in the provided filing.
• Footnote: The 2,922 units are RSUs; each RSU is a contingent right to receive one share of common stock upon vesting.

Context

• RSUs are not issued common shares until they vest; they represent a future right to receive shares (often subject to vesting conditions and potential tax withholding).
• This is a grant (compensation/retention tool), not an open-market purchase or sale, and does not by itself indicate immediate buying or selling pressure in the market.